FCGR2A
Low affinity immunoglobulin gamma Fc region receptor II-a
Also known as: CD32, CD32A, CDw32, Fc-gamma-RIIa, FCG2, FCG2A_HUMAN, FcgammaRIIa, FCGR2, FCGR2A1, IGFR2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P12318
- Gene
- FCGR2A
- Ensembl
- ENSG00000143226
- Chromosome
- 1
- Canonical length
- 317 aa
- Protein class
- CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Golgi apparatus,Plasma membrane
OverviewNCBI Gene
This gene encodes one member of a family of immunoglobulin Fc receptor genes found on the surface of many immune response cells. The protein encoded by this gene is a cell surface receptor found on phagocytic cells such as macrophages and neutrophils, and is involved in the process of phagocytosis and clearing of immune complexes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
317 residues, UniProt reviewed canonical sequence.
>P12318|FCGR2A
1 MTMETQMSQN VCPRNLWLLQ PLTVLLLLAS ADSQAAAPPK AVLKLEPPWI NVLQEDSVTL
61 TCQGARSPES DSIQWFHNGN LIPTHTQPSY RFKANNNDSG EYTCQTGQTS LSDPVHLTVL
121 SEWLVLQTPH LEFQEGETIM LRCHSWKDKP LVKVTFFQNG KSQKFSHLDP TFSIPQANHS
181 HSGDYHCTGN IGYTLFSSKP VTITVQVPSM GSSSPMGIIV AVVIATAVAA IVAAVVALIY
241 CRKKRISANS TDPVKAAQFE PPGRQMIAIR KRQLEETNND YETADGGYMT LNPRAPTDDD
301 KNIYLTLPPN DHVNSNNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FCGR2A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 127 nTPM
Expression across tissuesHPA
Tissue
- placenta: 127 nTPM
- appendix: 113 nTPM
- lung: 87 nTPM
- urinary bladder: 77 nTPM
- adipose tissue: 75 nTPM
- bone marrow: 52 nTPM
Single-cell type
- neutrophils: 452 nCPM
- macrophages: 110 nCPM
- monocytes: 109 nCPM
- cdc: 61 nCPM
- late spermatids: 57 nCPM
- microglia: 51 nCPM
Immune cell
- neutrophil: 2,531 nTPM
- eosinophil: 451 nTPM
- classical monocyte: 398 nTPM
- intermediate monocyte: 301 nTPM
- non-classical monocyte: 264 nTPM
- total PBMC: 189 nTPM
Brain region
- white matter: 48 nTPM
- medulla oblongata: 32 nTPM
- thalamus: 31 nTPM
- choroid plexus: 29 nTPM
- pons: 25 nTPM
- spinal cord: 24 nTPM
ReferencesPubMed · IEDB
Publications for FCGR2A from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
7 publications
- Suppressing anti-citrullinated protein antibody-induced osteoclastogenesis in rheumatoid arthritis using anti-CD64 and PAD-2 inhibitors.
2025 · Clin Exp Rheumatol · RCR 2.5 · 7 citations - Antibodies to C1q in systemic lupus erythematosus: characteristics and relation to Fc gamma RIIA alleles.
1997 · Kidney Int · RCR 1.7 · 77 citations - Conformational state of C-reactive protein is critical for reducing immune complex-triggered type I interferon response: Implications for pathogenic mechanisms in autoimmune diseases imprinted by type I interferon gene dysregulation.
2023 · J Autoimmun · RCR 1.6 · 12 citations - Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses.
2019 · Ann Rheum Dis · RCR 1.2 · 27 citations - Anti-interleukin 8 autoantibody:interleukin 8 immune complexes visualized by laser confocal microscopy in injured lung.
2007 · Arch Pathol Lab Med · RCR 0.5 · 22 citations
Show 2 more
- The Fc gammaRIIa polymorphism R/H131, autoantibodies against the platelet receptors GPIb alpha and Fc gammaRIIa and a risk for thromboembolism in lupus anticoagulant patients.
2005 · Thromb Haemost · RCR 0.2 · 8 citations - An IgM class anti-neutrophil cytoplasm antibody inhibits neutrophil adhesion and apoptosis via a Syk dependent signaling cascade.
2004 · Mol Immunol · RCR 0.2 · 7 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.35
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.35
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antibody-dependent cellular cytotoxicity
- cell surface receptor signaling pathway
- positive regulation of phagocytosis
- positive regulation of tumor necrosis factor production
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FCGR2A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FCGR2A as an antibody target. Whether an autoantibody or antibody against FCGR2A could matter depends on whether native FCGR2A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FCGR2A is annotated at the cell surface, where native FCGR2A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label FCGR2A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...